The global market for 1,2,3-Triacetyl-5-Deoxy-D-Ribose was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Triacetyl ribose is an important intermediate for the synthesis of capecitabine, and the capecitabine bulk drug can be prepared in three steps through a route reported in the literature. According to reports in the literature, the synthesis of triacetyl ribose is mainly based on the following two methods: one is using 1-methyl-5-deoxyribose as an intermediate, and triacetyl ribose is obtained through a two-step reaction; the second is using 5-deoxy-D -Ribose is an intermediate and triacetyl ribose is obtained by one-step acetylation. According to the synthetic method reported above, the prepared triacetyl ribose is a mixture of α and β isomers. The β isomer participates in the next reaction to prepare capecitabine. The α isomer is the impurity produced, and the α is different. The ratio of the structure is 3~30%, and the ratio of the α isomer will not be higher. The pure β isomer can be obtained by column chromatography or recrystallization at this isomer ratio.
North American market for 1,2,3-Triacetyl-5-Deoxy-D-Ribose was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for 1,2,3-Triacetyl-5-Deoxy-D-Ribose was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for 1,2,3-Triacetyl-5-Deoxy-D-Ribose was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key companies of 1,2,3-Triacetyl-5-Deoxy-D-Ribose include AlchemyPharm, Alfa Chemistry, Biosynth Carbosynth, Caming Pharmaceutical, Changzhou Joyous Chemical, Clearsynth, Hefei Home Sunshine Pharmaceutical Technology, Henan Eastar Chem.&Tech, Henan Tianfu Chemical, Ivy Fine Chemicals, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for 1,2,3-Triacetyl-5-Deoxy-D-Ribose, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of 1,2,3-Triacetyl-5-Deoxy-D-Ribose by region & country, by Type, and by Application.
The 1,2,3-Triacetyl-5-Deoxy-D-Ribose market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding 1,2,3-Triacetyl-5-Deoxy-D-Ribose.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of 1,2,3-Triacetyl-5-Deoxy-D-Ribose manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of 1,2,3-Triacetyl-5-Deoxy-D-Ribose in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of 1,2,3-Triacetyl-5-Deoxy-D-Ribose in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 1,2,3-Triacetyl-5-Deoxy-D-Ribose Product Introduction
1.2 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Market Size Forecast
1.2.1 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Value (2020-2031)
1.2.2 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Volume (2020-2031)
1.2.3 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Price (2020-2031)
1.3 1,2,3-Triacetyl-5-Deoxy-D-Ribose Market Trends & Drivers
1.3.1 1,2,3-Triacetyl-5-Deoxy-D-Ribose Industry Trends
1.3.2 1,2,3-Triacetyl-5-Deoxy-D-Ribose Market Drivers & Opportunity
1.3.3 1,2,3-Triacetyl-5-Deoxy-D-Ribose Market Challenges
1.3.4 1,2,3-Triacetyl-5-Deoxy-D-Ribose Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Players Revenue Ranking (2024)
2.2 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Revenue by Company (2020-2025)
2.3 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Players Sales Volume Ranking (2024)
2.4 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Volume by Company Players (2020-2025)
2.5 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Average Price by Company (2020-2025)
2.6 Key Manufacturers 1,2,3-Triacetyl-5-Deoxy-D-Ribose Manufacturing Base and Headquarters
2.7 Key Manufacturers 1,2,3-Triacetyl-5-Deoxy-D-Ribose Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of 1,2,3-Triacetyl-5-Deoxy-D-Ribose
2.9 1,2,3-Triacetyl-5-Deoxy-D-Ribose Market Competitive Analysis
2.9.1 1,2,3-Triacetyl-5-Deoxy-D-Ribose Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by 1,2,3-Triacetyl-5-Deoxy-D-Ribose Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in 1,2,3-Triacetyl-5-Deoxy-D-Ribose as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Purity 97%
3.1.2 Purity 98%
3.1.3 Purity 99%
3.2 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Value by Type
3.2.1 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Value, by Type (2020-2031)
3.2.3 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Value, by Type (%) (2020-2031)
3.3 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Volume by Type
3.3.1 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Volume, by Type (2020-2031)
3.3.3 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Volume, by Type (%) (2020-2031)
3.4 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Medicine
4.1.2 Chemical
4.1.3 Others
4.2 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Value by Application
4.2.1 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Value, by Application (2020-2031)
4.2.3 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Value, by Application (%) (2020-2031)
4.3 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Volume by Application
4.3.1 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Volume, by Application (2020-2031)
4.3.3 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Volume, by Application (%) (2020-2031)
4.4 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Value by Region
5.1.1 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Value by Region (2020-2025)
5.1.3 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Value by Region (2026-2031)
5.1.4 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Value by Region (%), (2020-2031)
5.2 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Volume by Region
5.2.1 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Volume by Region (2020-2025)
5.2.3 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Volume by Region (2026-2031)
5.2.4 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Volume by Region (%), (2020-2031)
5.3 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Value, 2020-2031
5.4.2 North America 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Value, 2020-2031
5.5.2 Europe 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Value, 2020-2031
5.6.2 Asia Pacific 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Value, 2020-2031
5.7.2 South America 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Value, 2020-2031
5.8.2 Middle East & Africa 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Value
6.2.1 Key Countries/Regions 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Value, 2020-2031
6.2.2 Key Countries/Regions 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Volume, 2020-2031
6.3 United States
6.3.1 United States 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Value, 2020-2031
6.3.2 United States 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Value by Type (%), 2024 VS 2031
6.3.3 United States 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Value, 2020-2031
6.4.2 Europe 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Value, 2020-2031
6.5.2 China 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Value by Type (%), 2024 VS 2031
6.5.3 China 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Value, 2020-2031
6.6.2 Japan 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Value, 2020-2031
6.7.2 South Korea 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Value, 2020-2031
6.8.2 Southeast Asia 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Value, 2020-2031
6.9.2 India 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Value by Type (%), 2024 VS 2031
6.9.3 India 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 AlchemyPharm
7.1.1 AlchemyPharm Company Information
7.1.2 AlchemyPharm Introduction and Business Overview
7.1.3 AlchemyPharm 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 AlchemyPharm 1,2,3-Triacetyl-5-Deoxy-D-Ribose Product Offerings
7.1.5 AlchemyPharm Recent Development
7.2 Alfa Chemistry
7.2.1 Alfa Chemistry Company Information
7.2.2 Alfa Chemistry Introduction and Business Overview
7.2.3 Alfa Chemistry 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Alfa Chemistry 1,2,3-Triacetyl-5-Deoxy-D-Ribose Product Offerings
7.2.5 Alfa Chemistry Recent Development
7.3 Biosynth Carbosynth
7.3.1 Biosynth Carbosynth Company Information
7.3.2 Biosynth Carbosynth Introduction and Business Overview
7.3.3 Biosynth Carbosynth 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Biosynth Carbosynth 1,2,3-Triacetyl-5-Deoxy-D-Ribose Product Offerings
7.3.5 Biosynth Carbosynth Recent Development
7.4 Caming Pharmaceutical
7.4.1 Caming Pharmaceutical Company Information
7.4.2 Caming Pharmaceutical Introduction and Business Overview
7.4.3 Caming Pharmaceutical 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Caming Pharmaceutical 1,2,3-Triacetyl-5-Deoxy-D-Ribose Product Offerings
7.4.5 Caming Pharmaceutical Recent Development
7.5 Changzhou Joyous Chemical
7.5.1 Changzhou Joyous Chemical Company Information
7.5.2 Changzhou Joyous Chemical Introduction and Business Overview
7.5.3 Changzhou Joyous Chemical 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Changzhou Joyous Chemical 1,2,3-Triacetyl-5-Deoxy-D-Ribose Product Offerings
7.5.5 Changzhou Joyous Chemical Recent Development
7.6 Clearsynth
7.6.1 Clearsynth Company Information
7.6.2 Clearsynth Introduction and Business Overview
7.6.3 Clearsynth 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Clearsynth 1,2,3-Triacetyl-5-Deoxy-D-Ribose Product Offerings
7.6.5 Clearsynth Recent Development
7.7 Hefei Home Sunshine Pharmaceutical Technology
7.7.1 Hefei Home Sunshine Pharmaceutical Technology Company Information
7.7.2 Hefei Home Sunshine Pharmaceutical Technology Introduction and Business Overview
7.7.3 Hefei Home Sunshine Pharmaceutical Technology 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Hefei Home Sunshine Pharmaceutical Technology 1,2,3-Triacetyl-5-Deoxy-D-Ribose Product Offerings
7.7.5 Hefei Home Sunshine Pharmaceutical Technology Recent Development
7.8 Henan Eastar Chem.&Tech
7.8.1 Henan Eastar Chem.&Tech Company Information
7.8.2 Henan Eastar Chem.&Tech Introduction and Business Overview
7.8.3 Henan Eastar Chem.&Tech 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Henan Eastar Chem.&Tech 1,2,3-Triacetyl-5-Deoxy-D-Ribose Product Offerings
7.8.5 Henan Eastar Chem.&Tech Recent Development
7.9 Henan Tianfu Chemical
7.9.1 Henan Tianfu Chemical Company Information
7.9.2 Henan Tianfu Chemical Introduction and Business Overview
7.9.3 Henan Tianfu Chemical 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Henan Tianfu Chemical 1,2,3-Triacetyl-5-Deoxy-D-Ribose Product Offerings
7.9.5 Henan Tianfu Chemical Recent Development
7.10 Ivy Fine Chemicals
7.10.1 Ivy Fine Chemicals Company Information
7.10.2 Ivy Fine Chemicals Introduction and Business Overview
7.10.3 Ivy Fine Chemicals 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Ivy Fine Chemicals 1,2,3-Triacetyl-5-Deoxy-D-Ribose Product Offerings
7.10.5 Ivy Fine Chemicals Recent Development
7.11 Jiangxi Chibang Pharmaceutical
7.11.1 Jiangxi Chibang Pharmaceutical Company Information
7.11.2 Jiangxi Chibang Pharmaceutical Introduction and Business Overview
7.11.3 Jiangxi Chibang Pharmaceutical 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Jiangxi Chibang Pharmaceutical 1,2,3-Triacetyl-5-Deoxy-D-Ribose Product Offerings
7.11.5 Jiangxi Chibang Pharmaceutical Recent Development
7.12 Shandong Boyuan Pharmaceutical
7.12.1 Shandong Boyuan Pharmaceutical Company Information
7.12.2 Shandong Boyuan Pharmaceutical Introduction and Business Overview
7.12.3 Shandong Boyuan Pharmaceutical 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Shandong Boyuan Pharmaceutical 1,2,3-Triacetyl-5-Deoxy-D-Ribose Product Offerings
7.12.5 Shandong Boyuan Pharmaceutical Recent Development
7.13 Watson
7.13.1 Watson Company Information
7.13.2 Watson Introduction and Business Overview
7.13.3 Watson 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Watson 1,2,3-Triacetyl-5-Deoxy-D-Ribose Product Offerings
7.13.5 Watson Recent Development
8 Industry Chain Analysis
8.1 1,2,3-Triacetyl-5-Deoxy-D-Ribose Industrial Chain
8.2 1,2,3-Triacetyl-5-Deoxy-D-Ribose Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Model
8.5.2 Sales Channel
8.5.3 1,2,3-Triacetyl-5-Deoxy-D-Ribose Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
Triacetyl ribose is an important intermediate for the synthesis of capecitabine, and the capecitabine bulk drug can be prepared in three steps through a route reported in the literature. According to reports in the literature, the synthesis of triacetyl ribose is mainly based on the following two methods: one is using 1-methyl-5-deoxyribose as an intermediate, and triacetyl ribose is obtained through a two-step reaction; the second is using 5-deoxy-D -Ribose is an intermediate and triacetyl ribose is obtained by one-step acetylation. According to the synthetic method reported above, the prepared triacetyl ribose is a mixture of α and β isomers. The β isomer participates in the next reaction to prepare capecitabine. The α isomer is the impurity produced, and the α is different. The ratio of the structure is 3~30%, and the ratio of the α isomer will not be higher. The pure β isomer can be obtained by column chromatography or recrystallization at this isomer ratio.
Published Date: 2024-01-17
Pages: 98
USD 2900.00
(Single User License)
Triacetyl ribose is an important intermediate for the synthesis of capecitabine, and the capecitabine bulk drug can be prepared in three steps through a route reported in the literature. According to reports in the literature, the synthesis of triacetyl ribose is mainly based on the following two methods: one is using 1-methyl-5-deoxyribose as an intermediate, and triacetyl ribose is obtained through a two-step reaction; the second is using 5-deoxy-D -Ribose is an intermediate and triacetyl ribose is obtained by one-step acetylation. According to the synthetic method reported above, the prepared triacetyl ribose is a mixture of α and β isomers. The β isomer participates in the next reaction to prepare capecitabine. The α isomer is the impurity produced, and the α is different. The ratio of the structure is 3~30%, and the ratio of the α isomer will not be higher. The pure β isomer can be obtained by column chromatography or recrystallization at this isomer ratio.
Published Date: 2024-04-12
Pages: 108
USD 4900.00
(Single User License)
Triacetyl ribose is an important intermediate for the synthesis of capecitabine, and the capecitabine bulk drug can be prepared in three steps through a route reported in the literature. According to reports in the literature, the synthesis of triacetyl ribose is mainly based on the following two methods: one is using 1-methyl-5-deoxyribose as an intermediate, and triacetyl ribose is obtained through a two-step reaction; the second is using 5-deoxy-D -Ribose is an intermediate and triacetyl ribose is obtained by one-step acetylation. According to the synthetic method reported above, the prepared triacetyl ribose is a mixture of α and β isomers. The β isomer participates in the next reaction to prepare capecitabine. The α isomer is the impurity produced, and the α is different. The ratio of the structure is 3~30%, and the ratio of the α isomer will not be higher. The pure β isomer can be obtained by column chromatography or recrystallization at this isomer ratio.
Published Date: 2024-01-07
Pages: 127
USD 3950.00
(Single User License)
The global market for 1,2,3-Triacetyl-5-Deoxy-D-Ribose was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-09
Pages: 102
USD 2900.00
(Single User License)
The global 1,2,3-Triacetyl-5-Deoxy-D-Ribose market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-08
Pages: 155
USD 4900.00
(Single User License)
The global 1,2,3-Triacetyl-5-Deoxy-D-Ribose market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-10
Pages: 94
USD 4250.00
(Single User License)
The global 1,2,3-Triacetyl-5-Deoxy-D-Ribose market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-18
Pages: 142
USD 2900.00
(Single User License)
The global market for 1,2,3-Triacetyl-5-Deoxy-D-Ribose was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 141
USD 3950.00
(Single User License)
Triacetyl ribose is an important intermediate for the synthesis of capecitabine, and the capecitabine bulk drug can be prepared in three steps through a route reported in the literature. According to reports in the literature, the synthesis of triacetyl ribose is mainly based on the following two methods: one is using 1-methyl-5-deoxyribose as an intermediate, and triacetyl ribose is obtained through a two-step reaction; the second is using 5-deoxy-D -Ribose is an intermediate and triacetyl ribose is obtained by one-step acetylation. According to the synthetic method reported above, the prepared triacetyl ribose is a mixture of α and β isomers. The β isomer participates in the next reaction to prepare capecitabine. The α isomer is the impurity produced, and the α is different. The ratio of the structure is 3~30%, and the ratio of the α isomer will not be higher. The pure β isomer can be obtained by column chromatography or recrystallization at this isomer ratio.
Published: 2024-01-17
Pages: 98
Triacetyl ribose is an important intermediate for the synthesis of capecitabine, and the capecitabine bulk drug can be prepared in three steps through a route reported in the literature. According to reports in the literature, the synthesis of triacetyl ribose is mainly based on the following two methods: one is using 1-methyl-5-deoxyribose as an intermediate, and triacetyl ribose is obtained through a two-step reaction; the second is using 5-deoxy-D -Ribose is an intermediate and triacetyl ribose is obtained by one-step acetylation. According to the synthetic method reported above, the prepared triacetyl ribose is a mixture of α and β isomers. The β isomer participates in the next reaction to prepare capecitabine. The α isomer is the impurity produced, and the α is different. The ratio of the structure is 3~30%, and the ratio of the α isomer will not be higher. The pure β isomer can be obtained by column chromatography or recrystallization at this isomer ratio.
Published: 2024-04-12
Pages: 108
Triacetyl ribose is an important intermediate for the synthesis of capecitabine, and the capecitabine bulk drug can be prepared in three steps through a route reported in the literature. According to reports in the literature, the synthesis of triacetyl ribose is mainly based on the following two methods: one is using 1-methyl-5-deoxyribose as an intermediate, and triacetyl ribose is obtained through a two-step reaction; the second is using 5-deoxy-D -Ribose is an intermediate and triacetyl ribose is obtained by one-step acetylation. According to the synthetic method reported above, the prepared triacetyl ribose is a mixture of α and β isomers. The β isomer participates in the next reaction to prepare capecitabine. The α isomer is the impurity produced, and the α is different. The ratio of the structure is 3~30%, and the ratio of the α isomer will not be higher. The pure β isomer can be obtained by column chromatography or recrystallization at this isomer ratio.
Published: 2024-01-07
Pages: 127
The global market for 1,2,3-Triacetyl-5-Deoxy-D-Ribose was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-09
Pages: 102
The global 1,2,3-Triacetyl-5-Deoxy-D-Ribose market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-08
Pages: 155
The global 1,2,3-Triacetyl-5-Deoxy-D-Ribose market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-10
Pages: 94
The global 1,2,3-Triacetyl-5-Deoxy-D-Ribose market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-18
Pages: 142
The global market for 1,2,3-Triacetyl-5-Deoxy-D-Ribose was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 141
REPORT COVERAGE
DESCRIPTION
MARKET SEGMENTATION
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report